Tronic's Microsystems SA | Small-cap | Technology

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 13.6M
Gross Profit 9.8M 71.63%
Operating Income 1.4M 9.94%
Net Income 2.7M 19.97%

Balance Sheet Metrics

Total Assets 13.1M
Total Liabilities 19.3M
Shareholders Equity -6.2M

Cash Flow Metrics

Operating Cash Flow 1.5M
Free Cash Flow 3.3M

Revenue & Profitability Trend

Tronic's Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue13.6M12.9M11.0M8.7M6.2M
Cost of Goods Sold3.9M3.7M2.9M3.8M3.0M
Gross Profit9.8M9.2M8.1M4.9M3.2M
Operating Expenses2.0M1.8M4.7M4.6M3.5M
Operating Income1.4M1.0M-345.0K-6.3M-7.4M
Pre-tax Income1.0M1.1M-415.0K-5.6M-9.1M
Income Tax34.0K61.0K61.0K26.0K17.0K
Net Income2.7M-5.2M-5.4M-5.6M-9.1M
EPS (Diluted)--€0.53-€0.56-€1.46-€2.38

Income Statement Trend

Tronic's Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets7.6M12.7M18.0M11.5M13.1M
Non-Current Assets5.5M5.8M5.9M13.8M14.9M
Total Assets13.1M18.4M23.9M25.3M28.0M
Liabilities
Current Liabilities18.2M24.3M23.4M45.6M42.4M
Non-Current Liabilities1.1M1.5M2.9M5.0M4.8M
Total Liabilities19.3M25.9M26.4M50.6M47.2M
Equity
Total Shareholders Equity-6.2M-7.4M-2.5M-25.3M-19.2M

Balance Sheet Composition

Tronic's Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income2.7M-5.2M-5.4M-5.6M-9.1M
Operating Cash Flow1.5M-1.9M-4.3M-6.3M-7.5M
Investing Activities
Capital Expenditures2.1M-1.1M-335.0K-856.0K-1.4M
Investing Cash Flow2.2M-1.1M-1.5M-831.0K-1.3M
Financing Activities
Dividends Paid-----
Financing Cash Flow-5.8M-1.3M3.7M4.4M13.8M
Free Cash Flow3.3M3.0M-2.9M-6.2M-8.1M

Cash Flow Trend

Tronic's Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 41.56
Price to Sales 4.41

Profitability Ratios

Profit Margin 5.36%
Operating Margin -1.29%
Return on Equity -11.75%
Return on Assets 2.17%

Financial Health

Current Ratio 0.46
Debt to Equity -2.08
Beta -0.00

Per Share Data

EPS (TTM) €0.16
Book Value per Share -€0.65
Revenue per Share €1.51

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
altro60.2M41.56--11.75%5.36%-2.08
Nanobiotix 178.2M-2.68-103.70%0.00%-0.77
Riber S.A 65.0M15.502.7618.41%10.02%16.54
Société Générale 37.4B8.500.534.37%19.91%4.05
Nokia Oyj 24.3B20.531.175.71%4.09%24.33
Capgemini SE 24.7B14.972.0515.06%7.56%51.68

Financial data is updated regularly. All figures are in the company's reporting currency.